• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
When to call it off: Defining the role of low-dose corticosteroids in thwarting the progression of non-severe COVID-19.何时叫停：界定低剂量皮质类固醇在阻止非重症新型冠状病毒肺炎进展中的作用
Ann Med Surg (Lond). 2021 Feb;62:236-238. doi: 10.1016/j.amsu.2021.01.063. Epub 2021 Jan 21.
2
Safety and Efficacy of Low-Dose Corticosteroids in Patients With Non-severe Coronavirus Disease 2019: A Retrospective Cohort Study.低剂量皮质类固醇对非重症2019冠状病毒病患者的安全性和有效性：一项回顾性队列研究
Cureus. 2021 Jan 7;13(1):e12544. doi: 10.7759/cureus.12544.
3
Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19.关于在非重症新型冠状病毒肺炎中使用皮质类固醇的专家共识声明
Indian J Crit Care Med. 2021 Nov;25(11):1280-1285. doi: 10.5005/jp-journals-10071-23923.
4
Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis.皮质类固醇治疗2019冠状病毒病症状的有效性：一项荟萃分析。
Med Clin (Engl Ed). 2022 Dec 23;159(12):575-583. doi: 10.1016/j.medcle.2022.03.020. Epub 2022 Dec 15.
5
Higher- versus Lower-Dose Corticosteroids for Severe to Critical COVID-19: A Systematic Review and Dose-Response Meta-analysis.高剂量与低剂量皮质类固醇治疗重症至危重新冠肺炎：系统评价和剂量反应荟萃分析。
Ann Am Thorac Soc. 2023 Apr;20(4):596-604. doi: 10.1513/AnnalsATS.202208-720OC.
6
Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness.阿那白滞素或大剂量皮质类固醇治疗低剂量地塞米松治疗后病情恶化的 COVID-19 肺炎患者：一项比较疗效的观察性研究。
Int J Infect Dis. 2023 Jan;126:87-93. doi: 10.1016/j.ijid.2022.11.017. Epub 2022 Nov 18.
7
Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis.糖皮质激素治疗 2019 年冠状病毒病症状的有效性：一项荟萃分析。
Med Clin (Barc). 2022 Dec 23;159(12):575-583. doi: 10.1016/j.medcli.2022.03.013. Epub 2022 May 3.
8
Evaluating the immediate and delayed effects of psychological need thwarting of online teaching on Chinese primary and middle school teachers' psychological well-being.评估在线教学中心理需求受挫对中国中小学教师心理健康的即时和延迟影响。
Front Psychol. 2022 Aug 16;13:943449. doi: 10.3389/fpsyg.2022.943449. eCollection 2022.
9
High-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: an observational study of comparative effectiveness.COVID-19 肺炎住院患者中使用大剂量皮质类固醇：一项比较疗效的观察性研究。
Int J Infect Dis. 2022 Dec;125:184-191. doi: 10.1016/j.ijid.2022.10.023. Epub 2022 Oct 29.
10
Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent.用于治疗新型冠状病毒肺炎的皮质类固醇：疗效、证据、期望及范围
Beni Suef Univ J Basic Appl Sci. 2021;10(1):78. doi: 10.1186/s43088-021-00165-0. Epub 2021 Nov 4.

引用本文的文献

1
Authors' response to the Letter to the Editor regarding: Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations.作者对致编辑的信的回复，主题为：针对感染新型冠状病毒肺炎并有症状患者的预防性家庭治疗及随后的远程会诊
Multidiscip Respir Med. 2021 Apr 13;16(1):768. doi: 10.4081/mrm.2021.768. eCollection 2021 Jan 15.

本文引用的文献

1
Safety and Efficacy of Low-Dose Corticosteroids in Patients With Non-severe Coronavirus Disease 2019: A Retrospective Cohort Study.低剂量皮质类固醇对非重症2019冠状病毒病患者的安全性和有效性：一项回顾性队列研究
Cureus. 2021 Jan 7;13(1):e12544. doi: 10.7759/cureus.12544.
2
Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study.早期使用皮质类固醇与 COVID-19 重症患者的死亡率降低有关：一项队列研究。
Crit Care. 2021 Jan 4;25(1):2. doi: 10.1186/s13054-020-03422-3.
3
A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19.COVID-19 非危重症患者皮质类固醇治疗的系统评价。
Sci Rep. 2020 Dec 1;10(1):20935. doi: 10.1038/s41598-020-78054-2.
4
Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.短期小剂量糖皮质激素治疗轻症 COVID-19 患者的效果。
Biomed Res Int. 2020 Sep 23;2020:2854186. doi: 10.1155/2020/2854186. eCollection 2020.
5
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study.早期、低剂量、短期使用皮质类固醇对非重症COVID-19肺炎成年住院患者的疗效评估：一项回顾性队列研究
Infect Dis Ther. 2020 Dec;9(4):823-836. doi: 10.1007/s40121-020-00332-3. Epub 2020 Sep 2.
6
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.地塞米松对中重度 COVID-19 相关急性呼吸窘迫综合征患者存活天数和无呼吸机天数的影响：CoDEX 随机临床试验。
JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.
7
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
8
A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.一项回顾性对照队列研究，探讨糖皮质激素治疗对 SARS-CoV-2 感染死亡率的影响。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.01168-20.
9
Short-Term Dexamethasone in Sars-CoV-2 Patients.新冠病毒患者的短期地塞米松治疗
R I Med J (2013). 2020 Jun 19;103(6):39-43.
10
Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19.COVID-19 住院患者的早期短程皮质类固醇治疗。
Clin Infect Dis. 2020 Nov 19;71(16):2114-2120. doi: 10.1093/cid/ciaa601.

When to call it off: Defining the role of low-dose corticosteroids in thwarting the progression of non-severe COVID-19.

作者信息

Almas Talal, Hussain Salman, Haadi Abdul, Ehtesham Maryam, Hassan Afnan, Khan Abdul Wali, Hameed Aamir

机构信息

RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Simon Fraser University, Surrey, British Columbia, Canada.

出版信息

Ann Med Surg (Lond). 2021 Feb;62:236-238. doi: 10.1016/j.amsu.2021.01.063. Epub 2021 Jan 21.

DOI:10.1016/j.amsu.2021.01.063
PMID:33520220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7825969/
Abstract
摘要